Prednisone Therapy in Kidney Disease

Beneficial Effects on Kidney Function

• The American Journal of Kidney Diseases recommends prednisone for patients with IgA nephropathy and minimal change disease, as it significantly reduces proteinuria and improves renal outcomes 1, 2, 3
• The American Journal of Kidney Diseases suggests that a 6-month course of corticosteroids provides long-term renal protection in IgA nephropathy with proteinuria >1 g/day despite optimized supportive care and GFR ≥50 mL/min/1.73 m² 3, 4

Disease-Specific Considerations

• The American Journal of Kidney Diseases indicates that patients with IgA nephropathy, persistent proteinuria >1 g/day despite 3-6 months of optimized supportive care, and GFR ≥50 mL/min/1.73 m² are optimal candidates for prednisone treatment 3, 4
• The Kidney International journal recommends prednisone for children with minimal change disease (steroid-sensitive nephrotic syndrome) 1, 5, 6, 7

Pharmacokinetic Advantages in CKD

• The American Journal of Kidney Diseases states that prednisone and methylprednisolone do not require dose adjustments based on GFR levels in CKD patients, making them preferable to medications requiring extensive modification 8

Adverse Renal Effects

• The American Journal of Kidney Diseases advises against using immunosuppressive therapy in patients with GFR <30 mL/min/1.73 m² unless there is crescentic glomerulonephritis with rapidly deteriorating kidney function 4

Practical Algorithm for Prednisone Use in Kidney Disease

• The American Journal of Kidney Diseases recommends confirming diagnosis with kidney biopsy when indicated, optimizing supportive care first, and assessing candidacy for prednisone based on GFR, proteinuria, and histology 3, 4
• The Kidney International journal suggests monitoring serum creatinine, GFR, proteinuria, potassium, and blood pressure regularly during prednisone treatment 8

Prednisone Use in Kidney Impairment

Therapeutic Benefits and Guidelines

• The KDIGO guidelines support prednisone use in glomerular diseases with appropriate patient selection 9

Specific Dosing and Precautions

• For immune-related nephritis, the ESMO guidelines recommend (methyl)prednisone 1-2 mg/kg 10, 11